Related Experiment Videos
Distribution studies of 111In-oxine-labeled peritoneal mononuclear cells in tumor-bearing rats
International Journal of Nuclear Medicine and Biology
|January 1, 1985
Summary
Killed tumor cells effectively sensitized normal rat peritoneal mononuclear cells (PMC) for enhanced tumor accumulation. This study demonstrates 111In-oxine labeling as a method to track mononuclear cell distribution in tumors.
Area of Science:
- Immunology
- Oncology
- Radiopharmacology
Background:
- Peritoneal mononuclear cells (PMC) play a role in anti-tumor immunity.
- Understanding the distribution of immune cells within tumors is crucial for developing effective cancer therapies.
Purpose of the Study:
- To investigate the in vivo distribution of 111In-labeled PMC in rats bearing carcinosarcoma (CS) tumors.
- To evaluate the effect of different antigenic stimulants on PMC accumulation in CS tumors.
Main Methods:
- PMC were obtained from normal rats or rats pretreated with BCG or irradiated CS cells.
- PMC were labeled in vitro with 111In-oxine.
- Labeled PMC were transferred to rats bearing CS tumors via tail-vein injection.
- Cell accumulation in tumors was quantified using an external gamma-ray camera at 24, 48, and 72 hours post-transfer.
Main Results:
- PMC from normal and BCG-treated rats showed similar, low accumulation (0.4% and 0.46% dose/g tumor, respectively).
- PMC from rats pre-exposed to killed CS cells exhibited significantly higher accumulation in CS tumors (0.79% dose/g tumor, P < 0.025).
- This indicates that prior exposure to killed tumor cells sensitizes PMC for enhanced tumor targeting.
Conclusions:
- Killed carcinosarcoma cells can sensitize peritoneal mononuclear cells, leading to increased accumulation in tumors.
- 111In-oxine labeling provides an effective method for studying the biodistribution of mononuclear cells within tumor microenvironments.
- These findings suggest potential strategies for enhancing immune cell delivery to tumors.